Hepatitis B core antibody-Positive liver recipients and hepatitis B reactivation after liver transplantation

Transplantation

Volumn 73, Issue 3, 2002, Pages 331-332

  Tur Kaspa, R ^a   Braun, M ^a   Ben Ari, Z ^a  

^a RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; IMMUNOSUPPRESSIVE AGENT; VIRUS DNA;

ANTIBODY DETECTION; ANTIGEN DETECTION; CLINICAL ARTICLE; DNA SEQUENCE; GRAFT REJECTION; HEPATITIS B; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPROPHYLAXIS; INFECTION RISK; LIVER TRANSPLANTATION; NOTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TREATMENT PLANNING; VIRUS DIAGNOSIS; VIRUS INFECTIVITY; VIRUS REACTIVATION;

EID: 0037084114     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200202150-00002     Document Type: Note

References (6)

1. Serological pattern "anti-HBC alone": Report on workshop
2. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic Tlymphocyte response
3. Can hepatitis B core antibody positive livers be used safely for transplantation: Hepatitis B virus detection in the liver of individuals who are hepatitis B core antibody positive
4. Reverse seroconversion of hepatitis B after allogeneic bone marrow transplantation
5. Failure of reactivation of hepatitis B after liver transplantation in hepatitis B surface antigen-negative, core antibody-positive recipients
6. De novo and apparent de novo hepatitis B virus infection after liver transplantation